Zhuhai Encode Medical Engineering Co., Ltd of Zhuhai at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Zhuhai Encode Medical Engineering Co., Ltd

No. 20, Honghui 2nd Road, Hongqi Industr Zone, Jiwan District, 519090 Zhuhai
Telephone +86 756 18575612272
Fax +86 756 3983809


Gillian Xu

International sales

NO.020, Honghui 2nd Road, Hongqi Industrial Zone, Jinwan District, Zhuhai,P.R. China 519090

+86 18575612272


Emily Wu

Sales Manager

NO.020, Honghui 2nd Road, Hongqi Industrial Zone, Jinwan District, Zhuhai,P.R. China 519090

+86 13825625670


Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Our products

Product category: Diagnostic rapid tests

Influenza A+B Antigen Rapid Test Device

Nasopharyngeal swab sample
Insert a sterilized swab into a nasal cavity securely from a nostril and collect
mucoepidermis wiping turbinate several times.
Pharyngeal swab sample
Insert a sterilized swab into pharynx and collect mucoepidermis mainly wiping flare region
of post-pharyngeal wall and palatine tonsil several times, and be careful not to make saliva
attach to the swab.
Nasopharyngeal aspirate
Connect an aspiration catheter to an aspiration trap that is attached to an aspiration device,
insert the catheter to nasal cavity from a nostril, start the aspiration device and then collect
nasal aspirate sample. Dip a sterilized swab into the collected nasal aspirate sample and
make the specimen cling to the swab.

More Less

Product category: Diagnostic rapid tests

SARS-CoV-2 Antigen Rapid Test

The SARS-COV-2 Antigen Rapid Test Device is a rapid visual
immunoassay for the qualitative, presumptive detection of COVID-19
antigens form throat swabs and nasopharyngeal swab specimens.
It is intended to be used by professionals as a test and provides a
preliminary test result to aid in the diagnosis of infection with novel
Any interpretation or use of this preliminary test result must also rely on
other clinical findings as well as on the professional judgment of health
care providers. Alternative test method(s) should be considered to confirm
the test result obtained by this test.

More Less

Product category: Diagnostic rapid tests

SARS-CoV-2 IgG/IgM Rapid Test

The SARS-CoV-2 IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) is a lateral flow immunoassay for the qualitative detection and differentiation of IgG and IgM of Novel Coronavirus (SARS-CoV-2) in human wholeblood,serum or plasma.
This test is intended to be used as an aid in the diagnosis of infection with Novel Coronavirus. Any reactive specimen with the SARS-CoV-2 IgG/IgM Rapid Test must be confirmed with alternative testing method(s).

More Less

About us

Company details

Founded in 1994, as one of China’s earliest developed enterprises in the circle of microbiological in vitro diagnostic reagents, Encode Medical Engineering Co., Ltd integrates research, production and sales and is running on a larger scale. Since the very beginning, Encode is consistently engaged in research and development of in-vitro diagnostic reagents. So far we have researched and developed series of microbiological and immunology reagents, which are used for laboratory diagnosis of mycoplasma, chlamydia, pneumonia, pathogenic fungus, tuberculosis, bacterial vaginosis, neisseria gonorrhoeae, etc. The sales network has covered all over the country.

In 2005, we constructed our study, research & manufacturing base in Zhuhai, a predominant city of biotech industry in south China, which covers 15,000m2. The base installed with automatic manufacturing lines including freeze-dry line and over 2,000m2 standard GMP air-purified workshops makes it definite for company to develop or larger scale, and with more intensive manufacturing and high technology.

We obtained ISO9001 & ISO13485 (Especially in Medical Device Manufacture Management) quality management system verification in 2006. From 2007 to 2009, after the new in-vitro diagnostic reagents regulations were issued, we successionally passed the rigorous quality management system evaluation organized by SFDA and GDFDA. And we also got class 3 certificates for our main products—Mycoplasma Susceptibility Test Kit, Fungi Susceptibility Test Kit, Chlamydia Trachomatis Antigen Testing Kit (Colloidal Gold) and M. tuberculosis Antibody (IgG) Testing Kit (Colloidal Gold).

Under “industry-study-research” collaboration mode, Encode has established extensive cooperative ties with Lanzhou University, South China University of Technology and Jinan University and has become teaching and practice base of College of Life Science, Lanzhou University, South China University of Technology and Zhuhai Health School. Encode enjoys a high reputation in this field and has been rated as one of Guangdong high-tech enterprises and national high-tech enterprises. Our president Sun Yifeng was elected as vice-chairman of CACLP and employed as an adjunct Professor of College of Life Sciences, Lanzhou University in 2008.

The R&D (research and development) center, directly led by the general manager, with numbers of experts and technicians on different levels, covers various fields. We are keeping innovating and improving based on feedbacks from market. We are also continuously investing in research, developing application scope & technology level of in-vitro diagnostic reagent in microbiology, immunology and molecular biology. With financial support from governments at different levels we have undertaken four research items (in process) and have been granted the title of national high-tech enterprise.

Sincerity and harmony are our faith; quality and efficiency are our targets. Relying on our scientific management, mature marketing strategy, years of manufacturing experience, good enterprise image and popular brand, we believe that we will provide you with the most professional service.

More Less